CA3016098C - Evaluation clinique de reponse de proteine m dans le myelome multiple - Google Patents

Evaluation clinique de reponse de proteine m dans le myelome multiple

Info

Publication number
CA3016098C
CA3016098C CA3016098A CA3016098A CA3016098C CA 3016098 C CA3016098 C CA 3016098C CA 3016098 A CA3016098 A CA 3016098A CA 3016098 A CA3016098 A CA 3016098A CA 3016098 C CA3016098 C CA 3016098C
Authority
CA
Canada
Prior art keywords
seq
amino acid
acid sequence
idiotypic antibody
chain domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3016098A
Other languages
English (en)
Other versions
CA3016098A1 (fr
Inventor
Stefan HARTLE
Original Assignee
Morphosys GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphosys GmbH filed Critical Morphosys GmbH
Priority claimed from PCT/EP2017/055011 external-priority patent/WO2017149122A1/fr
Publication of CA3016098A1 publication Critical patent/CA3016098A1/fr
Application granted granted Critical
Publication of CA3016098C publication Critical patent/CA3016098C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne un anticorps anti-idiotypique à MOR202 qui, lorsqu'il est fusionné à l'albumine humaine, déplace l'anticorps dans l'électrophorèse par immunofixation (IFE) atténuant ainsi toute interférence potentielle de MOR202 avec l'évaluation clinique de la protéine M.
CA3016098A 2016-03-04 2017-03-03 Evaluation clinique de reponse de proteine m dans le myelome multiple Active CA3016098C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16158714.2 2016-03-04
EP16158714 2016-03-04
PCT/EP2017/055011 WO2017149122A1 (fr) 2016-03-04 2017-03-03 Évaluation clinique de réponse de protéine m dans le myélome multiple

Publications (2)

Publication Number Publication Date
CA3016098A1 CA3016098A1 (fr) 2017-09-08
CA3016098C true CA3016098C (fr) 2025-09-23

Family

ID=

Similar Documents

Publication Publication Date Title
US20230203189A1 (en) Clinical assessment of m-protein response in multiple myeloma
CN111630068B (zh) 抗cd47抗体及其用途
CN110214154B (zh) 抗cd47抗体及其用途
AU2015265870B2 (en) PD-L1 antibodies and uses thereof
JP6564435B2 (ja) アルファ４ベータ７ヘテロ二量体特異抗体の投与
US12306183B2 (en) Immunofixation electrophoresis method with target component on-gel immunodisplacement
CA3016098C (fr) Evaluation clinique de reponse de proteine m dans le myelome multiple
JP2023510075A (ja) ヒト化抗ｃａ ｉｘ抗体、およびその使用方法
CN120441707B (zh) 结合特瑞普利单抗的抗体及其用途
HK1261804B (en) Clinical assessment of m-protein response in multiple myeloma
HK1261804A1 (en) Clinical assessment of m-protein response in multiple myeloma
CN120923624A (zh) 可结合人cd137单克隆抗体或其功能性片段及其应用
HK40013319A (en) Anti-cd47 antibody and use thereof